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Summary A study was made of the relatonship between the intrinsic radiosensifivity of human cervical tumours and the expression of the
DNA repair enzyme human apurnic/apyrmidinic endonuclease (HAP1). The radiosensitivity of clonogenic cells in tumour biopsies was
measured as surviving fraction at 2 Gy (SF2) using a soft agar assay. HAP1 expression levels were determined after staining of formalin-fixed
paraffin-embedded tumour sections with a rabbit antiserum raised against recombinant HAP1. Both measurements were obtained on
pretreatment biopsy material. All 25 tumours examined showed positive staining for HAP1, but there was heterogeneity in the level of
expression both within and between tumours. The average coefficients of variation for intra- and intertumour heterogeneity were 620o and 82%
respectively. There was a moderate but significant positive correlation between the levels of HAP1 expression and SF2 (r= 0.60, P = 0.002).
Hence, this study shows that there is some relationship between intrinsic radiosensitivity and expression of a DNA repair enzyme in cervical
carcinomas. The resutts suggest that this type of approach may be useful in the development of rapid predictive tests of tumour radiosensitivity.
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There is considerable interest in increasing the understanding of
the factors that determine the radiosensitivitv of cells from
different individuals (West. 1995). Exentuallv. these factors may
be exploited in the development of rapid assays for predicting the
radioresponsiveness of both normal and malignant cells. It has
been estimated that the theoretical benefits of radiosensitivitx
testin, could be substantial in terms of improxing outcome and
reducing morbidity for cancer patients undergoing radiotherapy
(MacKay et al. 1998).
The survixal of cells following exposure to radiation is
governed by complex interactions between a large number of
proteins inxolhed in DNA damage recognition. DNA repair and
the response of the cells to unrepaired or misrepaired DNA
damage. For example. absence ofcomponents ofthe DNA double-
strand break recognition complex DNA-PK has been identified as
a cause of radiosensitivitv in the hamster xrs6 line (lackinc the
Ku8O protein: Taccioli et al. 1994) and in the scid mouse (lacking
the p350 protein: Petersen et al. 1995). It is. therefore. reasonable
to suggest that variations in the lexels of expression of such
proteins may result in subtle variations in radiosensitivity.
The major lethal DNA lesion produced by ionizing radiation is
considered to be the double-strand break. possibly associated x%ith
other tvpes of end-structure damage at the break- to constitute
.clustered' damage (Ward. 1994). This may include apurinic/
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apynmidinic (API sites generated either du 'nn initial chemical
reactions after irradiation or as a result of the processing of base
lesions by components of the base excision repair path%vay see
Demple and Harrison. 1994). This latter pathvvay involves the
recognition of damage by a DNA repair glycosylase to produce
AP sites. which are subsequentlx incised by an AP Ivase or AP
endonuclease. The HAP1 (also known as APEI and APEX in the
mouse) protein is considered to be the major AP endonuclease in
human cells and has homology of structure and function to
Eschenrchia coli exonuclease III. which has been shown to play an
important role in DNA repair and response to ionizinc, radiation
(Cunningham et al. 1986). The HAP1 protein is identical to the
redox factor 1 protein (ref1). which has been show-n to be involved
in the redox regulation of DNA bindinc of transcription factors
such as c-fos and c-jun (Xanthoudakis and Curran. 1992).
Chen et al (1992) reported that two radiosensitive mouse
lymphoblastoid lines show~ved very lo%v expression levels of APEX
as deternmined bx Western analvsis and that their radiosensitivity
was reduced by transfection wvith a plasmid encoding HAP1.
Furthermore. in data reported by Ono et al (1995). there was a
trend towards an association betw-een HAP1 actixity and the
radiosensitivities of six human galioma cell lines.
The present study was caried out to examine the expression of
HAP1 in a series ofhuman cernical carcinomas that had previously
been assayed for radiosensitivity using a clonogenic assay (West et
al. 1997). The aim was to establish any relationship between the
two measurements. and so determiine the importance of HAP1
expression in the radiosensitivity ofprimary cen-ical carcinoma.
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Table 1 HAP1 expression in 25 cervical tumours
Sample HAPN SF2 Age Stage Histology p53 Outcome
V41 13+2 0.20+0.04 43 3b Mod. SCC 30-13 Alive at71 months
V93 14 -2 0.38 ± 0.03 47 1b Wel, SCC 11 +2 Alive at 27 months
V109 83 + 2 0.46 ± 0.04 65 1b Poor, SCC 14 3 Alive at 56 months
Vill 69 + 3 0.39 ± 0.04 52 2a Poor, SCC 3 ± 1 Alive at 64 months
V115 5+±2 0.48±0.04 40 2b Well, SCC 0 Deadat21 months (PR. METS)
V134 14+±14 0.19+0.04 44 2a Mod. SCC 0 Dead at 32 months (METS)
V135 23 - 3 0.29 ± 0.18 48 1b Mod. SCC 13 ± 1 Alive at 54 months
V137 24 7 0.66_0.05 44 3b Mod, SCC 5 1 Dead at 33 months (METS)
V138 33 3 0.29 ± 0.05 57 1b Mod. SCC 4 ± 1 Alive at 58 months
V144 13 5 0.23 ± 0.02 72 1b WelI. SCC 0 Alive at 50 months
Vl51 16 + 1 0.21 ± 0.02 66 1b Mod, SCC 0 Dead at 17 months (CR, PR. METS)
Vl54 11 1 0.33 ±0.05 30 2b Mod, SCC 0 Alive at55 months
V157 14 -2 0.43 ± 0.04 59 2b Mod. SCC 35 ± 4 Alive at 26 months
V158 0 0 0.43 ± 0.10 50 2b Mod.SCC 16 ± 1 Alive at 34 months
V207 95 _ 1 0.68±0.05 49 2a Mod.SCC 13± 1 Alive at 24 months
V209 73_5 0.77_0.14 71 1b Mod,SCC 13±2 Aliveat39months
V236 79 _ 2 0.57 ±0.06 57 3b Mod, SCC nd Dead at 32 months (METS)
V239 12 _ 2 0.23 ± 0.07 43 2b Poor. adeno nd Alive at 35 months
V240 22 4 0.24 ± 0.07 71 1b Mod, SCC nd Alive at 38 months
V243 76 3 0.79 ± 0.14 38 3b Mod, SCC nd Dead at 33months (CR)
V269 75 2 0.59 ± 0.11 71 3b SCC nd Dead at 22 months (CR. PR. METS)
V278 5 1 0.60_0.06 45 2b Well, SCC nd Alive at 22 months
V296 38 ± 3 0.38 ± 0.08 57 2a Mod, SCC nd Alive at 24 months
V298 69 3 0.36 ± 0.07 51 3b Mod, SCC nd Alive at 11 months
V299 73 _ 5 0.61 ± 0.10 37 3b SCC nd Dead at 3 months (CR. PR, METS)
HAP1 values are percentages and are the means and s.e. of ten randomly selected fields. SF2 values are the means and s.e. of 4-12 replicate tubes. Histology
is classified as either squamous cell carcinoma (SCC) or adenocarcinoma (adeno) and either well, moderately (mod) or poorly (poor) differentiated. p53 values
are percentages and are the means and s.e. of ten randomly selected fields (nd = not done). Patient outcome was classified as central (CR) or penpheral (PR)
recurrence. or metastases (METS).
MATERIALS AND METHODS
Preparation of HAP1 antiserum
An anti-rHAPl antiserum was produced by intramuscular injec-
tion of450 jg ofrHAPl in 350 jl of 50% Thtermax in phosphate-
buffered saline (PBS). split between two sites on each flank of a
Half-Lop rabbit. After 37 days. a boost was given of 200 jg of
rHAPl in 200 jl 50% Titermax in PBS. split between two sites. A
final boost of another 200 jg of rHAPl was given as above 57
days later. and blood was collected by cardiac puncture after 13
days. Antisera were screened for reactivity against HAP1 by both
Western blotting and antibody capture enzyme-linked immunosor-
bent assay (ELISA) using rHAPl polypeptide. Before use in
immunohistochemistry. total immunoglobulin G (IgG) was puri-
fied from both the preimmune serum and antiserum obtained from
the final bleed using a Bio-Rad Econo-Pac serum immunoglobulin
G purification kit.
Antibody specificity
Western blotting was used to demonstrate the specificity of the
polyclonal antiserum produced. Cell extracts from two human
tumour cell lines (A2780. K562) and two non-human lines (rat
Dunning prostate. CHO) were separated by sodium dodecyl
sulphate polyacrylamide gel electrophoresis (SDS-PAGE). The
separated proteins were then transferred by electroblotting onto
Hybond-C Super nitrocellulose membranes (Amersham. UK)
using the BioRad Mini Trans-blot apparatus. Transfer was carried
out for 1 h at 85 V. in Western transfer buffer (25 m-N Tris. 190 nmLi
glycine. 20% methanol). After blotting. the membrane was air
dried. wrapped in Saran Wrap and stored at 4 C until processed.
The membrane was wetted with PBS containing 0.3%c Tween-20
(PBST) and membrane-bound proteins stained with 0.11% black
India ink in PBST for approximately 30 min with agitation. Excess
ink was removed by washing with PBST for 30 min. and the
membrane incubated in TBST blocking buffer (5%c non-fat milk in
50mM1 Tris-HCl pH 7.5. 150 mv- sodium chlonrde. 0.1%7 v/x
Tween 20) for 1 h at room temperature. The membrane was incu-
bated with the primarv antiserum (anti-HAPI at 1:666 dilution) in
blocking buffer for 1.5 h at room temperature. Unbound antibody
was removed by washing three times in TBST. The secondary
antibody was then applied: goat-anti-rabbit IgG conjugated with
horseradish peroxidase (Dako). at a 1:2000 dilution in blocking
buffer. for 1 h at room temperature. After three more washes in
TBST. bound antibody was detected using a luminol-based chemi-
luminescence method (ECL. Amersham).
Immunohistochemistry of HAP1
Formalin-fixed. paraffin-embedded sections (5 jm thick) were
dewaxed in xylene for 10 min andrehydrated by passage through a
graded ethanol series to tap water. The sections were then treated
to unmask antigens bv microwaving in 11 of 10 nmi citrate buffer
(pH 6.0) for 25 min at 700 W. After cooling for 10 nmmn in the
buffer. the sections were cooled to room temperature by the addi-
tion of tap water and immersed in Tris-buffered saline (TBS).
Endogenous peroxidases were blocked with 3%7c hydrogen
peroxide in TBS for 20 mimn and the sections washed twice for
5 min in TBS. The sections were then blocked further using 10%7
normal swine serum (Dako) in TBS and the serum removed by
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tapping. Anti-rHAPI IgG (orIgG from preimmune serum) (100 jl
at 1:100 or 1:50 dilution in TBS) was added and the sections were
incubated at 4°C for 24 h. The sections were washed three times
for 5 min in TBS, and then incubated at room temperature for
30 miin with 100 1 of biotinylated swine anti-rabbit IgG heavy
and light chain antiserum (SARBO, Dako) at 1:400 in TBS.
Unbound SARBO was removed, the sections washed twice for
5 min in TBS and incubated at room temperature with 100gil of
biotinylated peroxidase-streptavidin complex (ABC, Dako) for
30 min. After washing twice for 5 min in TBS to remove unbound
ABC, the slides were stained with 100gl of nickel-DAB [1 fast-
DAB tablet (Sigma) and 1 fast-urea-hydrogen peroxide tablet
(Sigma) dissolved in 5 ml of0.1% nickel chloride] and incubated
at room temperature for 5 min. The DAB was removed, the
sections washed in rnning water for 10 min, dehydrated through
the graded ethanol series to xylene and mounted. Antibody
staining ofthe 25 tumour sections was carried out in two batches,
and four ofthe tumours were stained in both runs.
Quatification of HAP1 expression in tumour sections
The use ofthree tumour sections per slide enabled the examination
of non-specific staining using IgG from preimmune serum for all
25 tumours. Quantification of HAP1 expression in coded tumour
sections was carried out independendly by two investigators using
lightmicroscopy. Althoughexpression was seen in all tumourcells
examined, there was a clear distinction between weakly and
strongly staining cells. The majority ofthe tumours showed a vari-
ation in the staining intensity. The numberofstrong HAPI positive
cells were, therefore, counted in a total of 1000 tumour cells in ten
fields of 100 cells per field. lwhe HAPI positive values were
expressed as means and standard errors ofthe ten fields examined.
As the methods used in quantifying HAPI expression were subjec-
tive, image analysis techniques were investigated. The latter were,
however, found difficult to optimize because all cells showed
some degree ofstaining.
Immunohistochemistry of p53
Tumoursections weretreated asdescribedforHAP1 staining butthe
anti-p53 polyclonal antibody D07 (Novocastra) was used at a
concentration of 1:50 and TBS was used as the negative control.
Expression was assessed in 1000 tmou cells in ten fields of 100
cells per field to obtain the percentages of positively stained cells.
Values were expressedasmeans andstandarderrors oftheten fields.
Tumour radiosensitvity
The patient details, treatment protocols and assay method have
been described in detail elsewhere (West et al, 1997). The study
was performed following South Manchester Medical Research
Ethics Committee approval and only women with stage I-EI
proven carcinoma of the cervix who gave informed consent were
included in the study. Tumour specimens were received immedi-
ately before the commencement of radiotherapy. Samples were
disaggregated using an enzyme cocktail containing 0.4 mg ml-'
DNAase, and 0.5 mg ml- pronase and collagenase. Suspensions
were cultured using a soft agar clonogenic assay in Ham's F12
medium supplemented with 15% fetal calf serum, August rat
red blood cells, 10 ng mln- epidermal growth factor, 10 ig ml
insulin, 0.5 jig ml-l hydrocortisone and 2.5 gg ml- transferrin.
=37kDa~~~~~~~~~7 D
~28kDa
Figure 1 Westemn blot of cell lines of human and rodent ongin and E cob
exonuclease IlIl probed with the HAP1 anbserum. Lanes: (1) a human ovanan
carcnma ceH line, A2780; (2) a human eukaema cel fine, K562; (3) a
Duning rat prostate ne; (4) Chinese hamster ovary cels, CHO; (5) exo IIl
Radiosensitivity was determined as survival after a single in vitro
dose of 2 Gy radiation (SF,). SF, was calculated from the colony-
forming efficiencies of control and irradiated samples after 4
weeks' growth in an atmosphere of 5% carbon dioxide plus 5%
oxygen in nitrogen.
Data analysis
Relationships between quantitative variables were obtained by
using Pearson parametric correlations. A paired t-test was used to
determine statistical differences between datasets, and a signifi-
cance level of0.05 was used throughout.
RESULTS
Tlhe anti-HAPl antiserum produced was specific for a single 38-
kDa protein in human cells. Figure 1 illustrates this finding using
two human tumour cell lines (A2780, K562). No cross-reaction
was observed in rodent cells expressing high levels of AP-endo-
nuclease (CHO, a rat prostate line), nor against the E. coli struc-
tural homologue exonuclease JI (Figure 1). When used against
paraffin sections, all ofthe 25 cervical carcinomas examined show
some degree of HAP1 expression in both tumour and stromal
tissue. No non-specific staining was seen on any of the sections
trated with preimmune serum (not shown). The specificity ofthe
antibody wasdemonstatedbypreadsorbing the antiserum with gel
purified rHAPl before staining one tumour section (Figure 2B).
Only minimal and uniform staining of the entire section was
observed after this treatment indicating that the antiserum was
specific for HAP1 under the conditions used. The nuclear pattem
of HAPI staining varied between tumours, with some displaying
an intense and relatively uniform pattem whereas others demon-
strated a reticulate pattem. There was also a marked heterogeneity
in staining intensity between different tumours (Figure 2A. C and
D) and between nuclei within the sametumourtissue. The staining
was carried out in two batches with four tumours stained in both
runs. For these four tumours, there was good agreement of the
staining intensity between the different staining runs.
Only strongly stained tumour cells were scored as positive. A
listofthe levels ofHAPIl-positivecells is given in Table I in which
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FKgure 2 Formalin-fixed paraffin-embedded secbons of cervcal tumours were stained for HAP1 expression using an antiserum against rHAP1. No
counterstain was used. (A) Tumour secton with strong staining for HAP1. (B) The same tumour probed with preadsorbed rHAP1 antiserum. Also shown are
tumour sections with intermediate (C) and weak (D) staining
the data are given as means with standard errors of ten randomly-
selected microscope fields. The mean and standard deviation value
for HAPI expression was 38±31% (range 0-95%). The coefficient
of variation for inter-tumour heterogeneity was 82%. Intra-tumour
(i.e. interfield) variability in HAPI expression was seen with an
average coefficient of variation of 62%. These analyses illustrate
that there was greater heterogeneity of HAP1 expression between
tumours than within tumours. It is also noteworthy that the degree
of intra-tumour heterogeneity of staining was variable, e.g. the
coefficients of variation ranged from % to 13 1%.
To examine scoring reproducibihity, a comparison was made
between the data obtained independently by two individuals
(Figure 3). A significant positive correlation was seen (r = 0.84.
P < 0.001). These data show that the relative scores of HAPl
expression are reproducible betu-een different operators. However.
a paired t-test comparison ofthe data obtained by two independent
scorers showed that the absolute values obtained by each person
were significantly different (P < 0.044). This illustrates that.
although reproducible correlations can be obtained by two
independent investigators. assessment of the absolute levels of
HAPI expression is operator dependent and so it requires a single
individual to carry out the measurements within a given series.
This problem could be diminished by rescoring sections which
yielded different expression levels between operators or by using
a less quantitative method of scoring (e.g. classifying tumours
as +. ++. +++)
Radiosensitivity. measured as surviving fraction at 2 Gy (SF,).
was obtained as part of previous studies (West et al. 1997).
Increasing HAP expression correlated significantly with
decreasing intrinsic radiosensitivity. Figure 4 illustrates the data
obtained by one scorer but similar results were obtained by the
other scorer (r = 0.40. P = 0.046).
The clinical characteristics of the patients are listed in Table 1.
All patients were treated with radical radiotherapy alone. There
were no significant relationships between the level of HAP 1
expression and any of the clinical characteristics. Of the 25
patients studied. 17 were alive and well. and eicht had died of
cancer. The means (and standard errors) of HAPI levels for these
British Joumal of Cancer (1998) 78(9), 1128-1133
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Dr=0.8 P<O.OO1 * (e.g. Thacker and Wilkinson. 1991). To our knowledge. the present
study is the first to report a statisticallv significant positive correla-
so tion between the levels of in situ expression of a DNA repair protein
H _ and the relative radiosensitivity of a series of human tumours.
Support for our finding comes from the obser ation that overexpres-
4+ S> wsion of HAPI in two mouse lymphoblastoid cell lines with low
D- T endogenous AP expression conferred radioresistance (Chen et al.
1992). Also. although not statistically significant. a somewhat more
extensive study on six human alioma cell lines suggested a positive
I * association between HAP1 expression and radiosensitivity (Ono et
al. 1995). In this context. it should be noted that the levels of HAP1
in primary cells have been reported to be much lower than those in
immortal cell lines (La-Belle and Lin. 1984: Chen et al. 1991). so
that observations using primary material are probably more relevant
0- \ @ than those obtained using established cell lines. This may beimpor-
0 20 i 60 80 100 tant in considering the findings of other studies which indicated that
antisense-mediated reduction in the levels of HAP1 did not result in
Scorer 1 increased radiosensitivity in cell lines (Walker et al. 1994). and
HAP expression in 25 cervical tumours measured irxeperKenty IHAP1 mRNA levels did not correlate with radioresponsiveness in
rers. Data points arethe means and s.e. of ten fields within a human meningiomas and astrocytomas (Hughes-Davies et al. 1995).
bOil It should be noted thatin the latterstudy RNA levels were measured
rather than levels of the protein or its cellular localization. Indeed.
Duguid et al (1995) found that in many brain cells HAP1 was
r=0.60 P<0.002 located in the cytoplasm and not the nucleus: this mie,ht result in
radiosensitization because of reduced levels of nuclear protein avail-
able for DNA repair.
The moderate but significant correlation described in the present
study may. therefore, indicate that quantitation of HAP1 enzyme
D- expression is required to reveal any correlation. Alternatively.
cervical carcinoma may represent a unique case. perhaps because
D- z * of low levels of expression of other repair functions. A further
caveat to the degre of correlation between tumour SF. and
enzyme levels is that the former is measured on a small subpopula-
DO a i: 1tion of the whole tumour (the clonogenic cells). which is assessed
for enzyme levels. Extensive measurements of HAPI expression.
other relevant repair functions and radiosensitivity in a number of
different tumour types will be required to resolx e these issues.
0.0 0.2 0.4 0.6 0.8 1.0 HAP1 has both DNA repair and redox functions located in
Surviving fraction at 2 Gy different rerions of the protein. The DNA repair function is
reported to represent the most abundant apurinic/apvrimidinic
HAP1 expression vs intrinsic radiosensitivity, measured as endonuclease in the cell. but it is also known to recognize and act acton at 2 Gy. In 25 oervical carcinomas. HAP1 values are the
Is.e. of ten microscope fields (see legend to Figure 2). on 3'-terminal damage produced after exposure ofcells to ionizingy
bvity measurements are the means and s.e. of eight replicates radiation and certain chemical agents. It is currentlv accepted that
gle expeniment the lesions that are most closely correlated with survival after
ionizing radiation are DNA double-strand breaks (Ward. 1994).
This has been further refined to double-strand breaks persisting at
ps were 35±7%7 and 45±12%cc respectively. Although a specified period after exposure (Wurm et al. 1994). and recent
pression tended to be lower in the alive and well group. reports further suggest that. in addition. detection of misrepaired
ence did not reach statistical significance (P = 0.31) lesions may increase the accuracy of prediction of cellular
Wel of p53 expression was examined in 16 ofthe tumours radiosensitivity (Dahm-Daphi and Dikomey. 1996). Because it
ata are aiven in Table 1. A comparison was made of the blocks DNA polymerase and DNA ligase. it is reasonable to
IAPI expression in the five tumours with no mutant p53 sugest that 3'-terminal damage could. w-here HAP1 levels are
n with the 11 tumours with some expression. The mean limiting. be responsible for the cell's inability to repair double-
HAP1 positive cells for the two groups were 12c and strand breaks. and that such lesions may be the basis of some
ectively. There was a significantly higher level of HAP1 misrepair as a consequence of the attempts of the cellular repair
n in p53 positive tumours (P = 0.02). machinerv to circumvent the lesion.
It is also possible that the effect of HAP1 expression on cellular
SSION radiosensitivity may be related to its other functions. The latter are
the redox control of transcription factor (AP-1 binding to DNA
work has demonstrated that DNA repair mutants that are (Xanthoudakis and Curran. 1992) and the redox-dependent and
[y lacking in specific repair functions can be radiosensitive -independent stimulation ofp53 (Jayaraman et al. 1997). For 16 of
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the tumours studied, data were available on the expression of
mutant p53 protein. In tumours with no mutant p53 expression,
there were significantly lower levels of HAPI compared with
tumours with some expression. Although the tumour numbers are
small, the last observation may be related to the finding, described
above, of HAPI stimulation ofwildtype p53 protein. Transfection
studies using HAP1 cDNA mutated in the redox orrepair domains
would help to address this question.
Irrespective of the basis of the relationship between the in situ
levels of expression of HAPI and SF,, the present findings may
have important clinical implications. Measurements of tumour
radiosensitivity have been shown to be prognostic for outcome
following radiotherapy (West et al, 1997). However, the clono-
genic determination of SF, is both time consuming and labour
intensive, and so there is a need todevelop arapidpredictive assay
for tumour radiosensitivity. Our results indicate that, at least for
cervical carcinoma, quantitation of the expression of HAP1 and
probably other repair enzymes relevant to ionizing radiation
damage may be useful.
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